Lifeward to Report Third Quarter Financial Results on November 12, 2024
November 05, 2024 16:38 ET | Source: Lifeward, Ltd. MARLBOROUGH, Mass. and…
Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
YARDLEY, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical…
FTC Solar to Announce Third Quarter Financial Results Tuesday, November 12, 2024
AUSTIN, Texas, Nov. 05, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq:…
Golden Matrix Group to Announce Third Quarter Financial Results on November 12, 2024
LAS VEGAS, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Golden Matrix Group Inc.…
Core Molding Technologies Reports Fiscal 2024 Third Quarter Results
COLUMBUS, Ohio, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc.…
The Adecco Group: Q3 2024 RESULTS
Robust performance in challenging markets; volumes stabilising ZURICH, Nov. 5, 2024 /PRNewswire/…
Descartes Sets Date to Announce Third Quarter Fiscal 2025 Financial Results
November 04, 2024 06:45 ET | Source: The Descartes Systems Group Inc…
Kia announces October 2024 global sales results
October 2024 global sales of 264,854 units, up 2.8% Y/yOutside of Korea,…
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch…
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase…